Effects of Continuous Positive Airway Pressure and Valsartan Treatments on Arterial Blood Pressure in OSAS Patients
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The main objective of the study is to compare the decrease of mean arterial blood pressure
over 24 hours in patients having obstructive sleep apnea syndrome and weak or moderate
hypertension, treated by Valsartan 160mg per day versus continuous Positive Airway Pressure.